| HOME >> MEDICINE >> TECHNOLOGY |
4. REST OF WORLD III-55
A.Market Analysis III-55
Outlook III-55
Heparin Market in China Gains Momentum III-55
Product Introduction/Approval III-55
Focus on Select Player III-56
B.Market Analytics III-57
Table 58: Rest of World Recent Past, Current & Future
Analysis for Anticoagulants by Product Segment - Oral
Anticoagulants and Injectable Anticoagulants (Unfractionated
Heparin and Low Molecular Weight Heparin) Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-57
Table 59: Rest of World Historic Review for Anticoagulants
by Product Segment - Oral Anticoagulants and Injectable
Anticoagulants (Unfractionated Heparin and Low Molecular
Weight Heparin) Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-58
Table 60: Rest of World 15-Year Perspective for
Anticoagulants by Product Segment - Percentage Breakdown of
Dollar Sales for Oral Anticoagulants and Injectable
Anticoagulants (Unfractionated Heparin and Low Molecular
Weight Heparin) Markets for the Years 2004, 2011 & 2018
(includes corresponding Graph/Chart) III-59
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 45 (including Divisions/Subsidiaries - 53)
The United States (24)
Canada (1)
Japan (3)
Europe (13)
- France (1)
- Germany (4)
- The United Kingdom (4)
- Rest of Europe (4)
Asia-Pacific (Excluding Japan) (11)
Latin America (1)
To order this report:
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |